Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes

Launched by WHOLE ENDO · Jun 27, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help people with type 2 diabetes that isn’t well controlled. The study looks at whether using a device called a continuous glucose monitor (CGM), combined with virtual group meetings that provide diabetes education and peer support, can help improve blood sugar levels and overall quality of life. During these online group visits, participants will learn how to use the CGM, understand their blood sugar patterns, and get tips on healthy eating, physical activity, reducing stress, and building new habits to better manage their diabetes.

Adults aged 18 and older with type 2 diabetes and a blood sugar level above the target range (measured by a test called Hemoglobin A1c greater than 8%) may be eligible to join, as long as they have a smartphone to connect to the CGM device. People who are pregnant, undergoing cancer treatment, have certain serious health conditions, or have type 1 diabetes would not be eligible. If you join the study, you’ll participate in virtual group sessions and use the CGM to help track your blood sugar throughout the day, with support from healthcare professionals and others managing diabetes like you. This study is currently recruiting participants who want to try a new, supportive way to manage their diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 18 years and older
• • Diagnosed with type 2 diabetes mellitus Hemoglobin A1c \>8% Must have smartphone to connect with continuous glucose monitor
• Exclusion Criteria:
• • Pregnancy Use of steroids Active cancer treatment Terminal illness Dementia, mental impairment Type 1 diabetes End stage renal disease, on dialysis